Cargando…

Emerging Direct Targeting β-Catenin Agents

Aberrant accumulation of β-catenin in the cell nucleus as a result of deregulation of the Wnt/β-catenin pathway is found in various types of cancer. Direct β-catenin targeting agents are being researched despite obstacles; however, specific β-catenin drugs for clinical treatments have not been appro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalli, Marianna, Masci, Domiziana, Urbani, Andrea, La Regina, Giuseppe, Silvestri, Romano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698307/ https://www.ncbi.nlm.nih.gov/pubmed/36431838 http://dx.doi.org/10.3390/molecules27227735

Ejemplares similares

Emerging Therapeutic Agents for Colorectal Cancer
por: Nalli, Marianna, et al.
Publicado: (2021)

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
por: Masci, Domiziana, et al.
Publicado: (2023)

4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells
por: Masci, Domiziana, et al.
Publicado: (2023)

Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor
por: Puxeddu, Michela, et al.
Publicado: (2022)

Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer
por: Nardella, Caterina, et al.
Publicado: (2021)

Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents
por: Coluccia, Antonio, et al.
Publicado: (2019)

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
por: Pelliccia, Sveva, et al.
Publicado: (2017)

Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor
por: Coluccia, Antonio, et al.
Publicado: (2022)

Modeling Epac1 interactions with the allosteric inhibitor AM-001 by co-solvent molecular dynamics
por: Bufano, Marianna, et al.
Publicado: (2020)

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy
por: Saponaro, Concetta, et al.
Publicado: (2018)

Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
por: Selvaggi, Federico, et al.
Publicado: (2022)

Discovery of a Novel Class of Norovirus Inhibitors with High Barrier of Resistance
por: Van Dycke, Jana, et al.
Publicado: (2021)

Targeting the Wnt/β-catenin signaling pathway in cancer
por: Zhang, Ya, et al.
Publicado: (2020)

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway
por: Jeong, Woo-Jeong, et al.
Publicado: (2018)

Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers
por: Catalano, Teresa, et al.
Publicado: (2023)

Wnt/β-catenin signaling in cancers and targeted therapies
por: Yu, Fanyuan, et al.
Publicado: (2021)

β-Catenin: oncogenic role and therapeutic target in cervical cancer
por: Wang, Bingqi, et al.
Publicado: (2020)

Aptamers and Their Potential to Selectively Target Aspects of EGF, Wnt/β-Catenin and TGFβ–Smad Family Signaling
por: Conidi, Andrea, et al.
Publicado: (2013)

Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions
por: Yang, Tinglin, et al.
Publicado: (2023)

Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma
por: Zhang, Guo-Feng, et al.
Publicado: (2020)

Targeting the canonical Wnt/β-catenin pathway in hematological malignancies
por: Ashihara, Eishi, et al.
Publicado: (2015)

Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss
por: Choi, Bu Young
Publicado: (2020)

Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics
por: Pandey, Pratibha, et al.
Publicado: (2023)

Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis
por: Song, Xiaowen, et al.
Publicado: (2015)

Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia
por: Thanendrarajan, S., et al.
Publicado: (2011)

Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma
por: Sha, Ying-Li, et al.
Publicado: (2019)

Molecular regulation and pharmacological targeting of the β‐catenin destruction complex
por: van Kappel, Eline C, et al.
Publicado: (2017)

β-Catenin signaling in hepatocellular carcinoma
por: Xu, Chuanrui, et al.
Publicado: (2022)

WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Martinez-Font, Esther, et al.
Publicado: (2021)

Antimicrobial agent chloroxylenol targets β-catenin-mediated Wnt signaling and exerts anticancer activity in colorectal cancer
por: Sun, Qi, et al.
Publicado: (2023)

Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway
por: Vallée, Alexandre, et al.
Publicado: (2020)

Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer
por: Zhu, Gui-Xian, et al.
Publicado: (2021)

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
por: Zhang, Yiyin, et al.
Publicado: (2018)

Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling
por: Hu, Lichao, et al.
Publicado: (2022)

The natural agent rhein induces β‐catenin degradation and tumour growth arrest
por: Liu, Shu, et al.
Publicado: (2017)

β catenin in health: A review
por: Prakash, Sharada, et al.
Publicado: (2015)

Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy
por: Lorenzon, Alessandra, et al.
Publicado: (2017)

Wnt/β-Catenin Signaling in Liver Cancers
por: Wang, Wenhui, et al.
Publicado: (2019)

Wnt/β-Catenin Signaling in Oral Carcinogenesis
por: Reyes, Montserrat, et al.
Publicado: (2020)

Connexin43 Carboxyl-Terminal Domain Directly Interacts with β-Catenin
por: Spagnol, Gaelle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6lvr6pk225rcf8lvmv9ev9095m